Company intelligence / Profile preview

Hebei Aoxing Pharmaceutical Group

Shijiazhuang, Hebei Province, China

Ownership: Private
Development stage: Other

Overview

Hebei Aoxing Pharmaceutical Group is a specialty pharmaceutical company focused on narcotics and pain management products. The company has the largest manufacturing facility and product pipeline for highly regulated narcotic medicines in China, with multiple drugs approved for commercial distribution and several in clinical development.[4][6][10]

Therapeutic areas: OtherCardiovascularNeurologyInfectious DiseasesGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Johnson Matthey Plc (joint venture for API production)Macfarlan Smith Ltd. (subsidiary of Johnson Matthey)QRxPharmaPhoenix PharmaLabs, Inc.American Oriental Bioengineering, Inc.

Beyond the preview

Go deeper on Hebei Aoxing Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Aoxing Pharmaceutical Group.

Explore the full profile